Stephen Maxted Ansell, MD, PhD

  • 20939 Citations
  • 77 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1983 2019

2018
11 Citations (Scopus)

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements

Luchtel, R., Dasari, S., Oishi, N., Pedersen, M. B., Hu, G., Rech, K. L., Ketterling, R. P., Sidhu, J., Wang, X., Katoh, R., Dogan, A., Kip, N. S., Cunningham, J. M., Sun, Z., Baheti, S., Porcher, J. C., Said, J. W., Jiang, L., Hamilton-Dutoit, S. J., Møller, M. B. & 10 others, Nørgaard, P., Bennani, N., Chng, W. J., Huang, G., Link, B. K., Facchetti, F., Cerhan, J. R., D’Amore, F., Ansell, S. M. & Feldman, A. L., Sep 27 2018, In : Blood. 132, 13, p. 1386-1398 13 p.

Research output: Contribution to journalArticle

Anaplastic Large-Cell Lymphoma
Cues
Genes
T-cells
DNA
12 Citations (Scopus)

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia

Abeykoon, J. P., Paludo, J., King, R., Ansell, S. M., Gertz, M., LaPlant, B. R., Halvorson, A. E., Gonsalves, W., Dingli, D. M., Fang, H., Rajkumar, S. V., Lacy, M., He, R., Kourelis, T., Reeder, C. B., Novak, A. J., McPhail, E., Viswanatha, D. S., Witzig, T. E., Go, R. S. & 10 others, Habermann, T. M., Buadi, F. K., Dispenzieri, A., Leung, N., Lin, Y., Thompson, C. A., Hayman, S. R., Kyle, R. A., Kumar, S. K. & Kapoor, P., Feb 1 2018, In : American Journal of Hematology. 93, 2, p. 187-194 8 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Mutation
Survival
Genotype
Myelodysplastic Syndromes
86 Citations (Scopus)

Nivolumab for relapsed/refractory classic hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: Extended follow-up of the multicohort single-arm phase II checkmate 205 trial

Armand, P., Engert, A., Younes, A., Fanale, M., Santoro, A., Zinzani, P. L., Timmerman, J. M., Collins, G. P., Ramchandren, R., Cohen, J. B., De Boer, J. P., Kuruvilla, J., Savage, K. J., Trneny, M., Shipp, M. A., Kato, K., Sumbul, A., Farsaci, B. & Ansell, S. M., May 10 2018, In : Journal of Clinical Oncology. 36, 14, p. 1428-1439 12 p.

Research output: Contribution to journalArticle

Cell Transplantation
Hodgkin Disease
Disease Progression
Safety
Advisory Committees
4 Citations (Scopus)

Outcomes among North American patients with diffuse large b-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression

Tracy, S. I., Habermann, T. M., Feldman, A. L., Maurer, M. J., Dogan, A., Perepu, U. S., Syrbu, S., Ansell, S. M., Thompson, C. A., Weiner, G. J., Nowakowski, G. S., Allmer, C., Slager, S. L., Witzig, T. E., Cerhan, J. R. & Link, B. K., Jan 31 2018, In : Haematologica. 103, 2, p. 297-303 7 p.

Research output: Contribution to journalArticle

Oncogenic Viruses
Lymphoma, Large B-Cell, Diffuse
Human Herpesvirus 4
Immunosuppression
Confidence Intervals
5 Citations (Scopus)

PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness

He, R., Ding, W. D., Viswanatha, D. S., Chen, D., Shi, M., Van Dyke, D., Tian, S., Dao, L. N., Parikh, S. A., Shanafelt, T. D., Call, T. G., Ansell, S. M., Leis, J. F., Mai, M., Hanson, C. A. & Rech, K. L., Jan 1 2018, In : American Journal of Surgical Pathology. 42, 7, p. 843-854 12 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
Biomarkers
Immunotherapy
Neoplasms

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia

Abeykoon, J. P., Zanwar, S., Ansell, S. M., Winters, J., Gertz, M., King, R., Murray, D., Habermann, T. M., Dingli, D. M., Muchtar, E., Go, R. S., Leung, N., Inwards, D. J., Buadi, F. K., Dispenzieri, A., Lacy, M., Lin, Y., Gonsalves, W., Kourelis, T., Witzig, T. E. & 5 others, Thompson, C. A., Rajkumar, S. V., Kyle, R. A., Kumar, S. K. & Kapoor, P., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Immunoglobulin M
Viscosity
Serum
Survival
1 Citation (Scopus)

Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma

Mackrides, N., Chapman, J., Larson, M. C., Ramos, J. C., Toomey, N., Lin, P., Maurer, M. J., Rafaelle, M., Tan, Y., Ikpatt, O., Syrbu, S., Ansell, S. M., Habermann, T. M., Link, B. K., Feldman, A. L., Lossos, I. S., Cerhan, J. R. & Vega, F., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Follicular Lymphoma
Human Herpesvirus 4

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

Zanwar, S., Abeykoon, J. P., Ansell, S. M., Gertz, M., Dispenzieri, A., Muchtar, E., Sidana, S., Tandon, N., Rajkumar, S. V., Dingli, D. M., Go, R., Lacy, M., Kourelis, T., Witzig, T. E., Inwards, D., Buadi, F., Gonsalves, W., Habermann, T. M., Johnston, P. B., Nowakowski, G. S. & 3 others, Kyle, R. A., Kumar, S. K. & Kapoor, P., Jan 1 2018, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Primary amyloidosis
1 Citation (Scopus)

Reply to Castillo et al.

Abeykoon, J. P., King, R., Ansell, S. M., Rajkumar, S. V., Paludo, J., Kyle, R. A., Kumar, S. K., Gertz, M. & Kapoor, P., Mar 1 2018, In : American Journal of Hematology. 93, 3, p. E71-E73

Research output: Contribution to journalLetter

26 Citations (Scopus)

Single-agent ibrutinib in relapsed or refractory follicular lymphoma: A phase 2 consortium trial

Bartlett, N. L., Costello, B., LaPlant, B. R., Ansell, S. M., Kuruvilla, J. G., Reeder, C. B., Thye, L. S., Anderson, D. M., Krysiak, K., Ramirez, C., Qi, J., Siegel, B. A., Griffith, M., Griffith, O. L., Gomez, F. & Fehniger, T. A., Jan 11 2018, In : Blood. 131, 2, p. 182-190 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Refractory materials
Disease-Free Survival
Mutation
Positron emission tomography
5 Citations (Scopus)

Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia

Jalali, S., Price-Troska, T., Paludo, J., Villasboas, J., Kim, H. J., Yang, Z. Z., Novak, A. J. & Ansell, S. M., Aug 14 2018, In : Blood Advances. 2, 15, p. 1985-1997 13 p.

Research output: Contribution to journalArticle

Open Access
Waldenstrom Macroglobulinemia
Ligands
T-Lymphocytes
Interleukin-6
Bone Marrow

Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells

Paulus, A., Manna, A., Akhtar, S., Paulus, S. M., Sharma, M., Coignet, M. V., Jiang, L., Roy, V., Witzig, T. E., Ansell, S. M., Allan, J., Furman, R., Aulakh, S., Manochakian, R., Ailawadhi, S., Chanan Khan, A. A. & Sher, T., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cytophagocytosis
Antibodies
B-Lymphocytes
Cell Death
1 Citation (Scopus)

Targeting myddosome signaling in Waldenstrom's macroglobulinemia with the interleukin-1 receptor-associated kinase 1/4 inhibitor R191

Ni, H., Shirazi, F., Baladandayuthapani, V., Lin, H., Kuiatse, I., Wang, H., Jones, R. J., Berkova, Z., Hitoshi, Y., Ansell, S. M., Treon, S. P., Thomas, S. K., Lee, H. C., Wang, Z., Eric Davis, R. & Orlowski, R. Z., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6408-6420 13 p.

Research output: Contribution to journalArticle

Interleukin-1 Receptor-Associated Kinases
Waldenstrom Macroglobulinemia
NF-kappa B
Cell Line
Cyclin-Dependent Kinase 6
10 Citations (Scopus)

T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines

Horwitz, S. M., Ansell, S. M., Ai, W. Z., Barnes, J., Barta, S. K., Choi, M., Clemens, M. W., Dogan, A., Greer, J. P., Halwani, A., Bradley, M. H., Hoppe, R. T., Jacobsen, E., Jagadeesh, D., Kim, Y. H., Lunning, M. A., Mehta, A., Mehta-Shah, N., Oki, Y., Olsen, E. A. & 11 others, Pro, B., Rajguru, S. A., Shanbhag, S., Shustov, A., Sokol, L., Torka, P., Wilcox, R., William, B., Zain, J., Dwyer, M. A. & Sundar, H., Feb 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 2, p. 123-135 13 p.

Research output: Contribution to journalReview article

T-Cell Lymphoma
Natural Killer T-Cells
Guidelines
Extranodal NK-T-Cell Lymphoma
Nose

The Bone Marrow Microenvironment in Waldenström Macroglobulinemia

Jalali, S. & Ansell, S. M., Jan 1 2018, (Accepted/In press) In : Hematology/Oncology Clinics of North America.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Immunoglobulin M
Bone Marrow
B-Cell Lymphoma
Bone Marrow Cells
2 Citations (Scopus)

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

McMaster, M. L., Berndt, S. I., Zhang, J., Slager, S. L., Li, S. A., Vajdic, C. M., Smedby, K. E., Yan, H. D., Birmann, B. M., Brown, E. E., Smith, A., Kleinstern, G., Fansler, M. M., Mayr, C., Zhu, B., Chung, C. C., Park, J. H., Burdette, L., Hicks, B. D., Hutchinson, A. & 61 others, Teras, L. R., Adami, H. O., Bracci, P. M., McKay, J., Monnereau, A., Link, B. K., Vermeulen, R. C. H., Ansell, S. M., Maria, A., Diver, W. R., Melbye, M., Ojesina, A. I., Kraft, P., Boffetta, P., Clavel, J., Giovannucci, E., Besson, C. M., Canzian, F., Travis, R. C., Vineis, P., Weiderpass, E., Montalvan, R., Wang, Z., Yeager, M., Becker, N., Benavente, Y., Brennan, P., Foretova, L., Maynadie, M., Nieters, A., de Sanjose, S., Staines, A., Conde, L., Riby, J., Glimelius, B., Hjalgrim, H., Pradhan, N., Feldman, A. L., Novak, A. J., Lawrence, C., Bassig, B. A., Lan, Q., Zheng, T., North, K. E., Tinker, L. F., Cozen, W., Severson, R. K., Hofmann, J. N., Zhang, Y., Jackson, R. D., Morton, L. M., Purdue, M. P., Chatterjee, N., Offit, K., Cerhan, J. R., Chanock, S. J., Rothman, N., Vijai, J., Goldin, L. R., Skibola, C. F. & Caporaso, N. E., Dec 1 2018, In : Nature Communications. 9, 1, 4182.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
loci
magnetic permeability
Lymphoma
Alleles

Waldenström macroglobulinemia

Fonseca, R. & Ansell, S. M., Nov 19 2018, Wintrobe's Clinical Hematology: Fourteenth Edition. Wolters Kluwer Health Pharma Solutions (Europe) Ltd, p. 6625-6649 25 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Waldenstrom Macroglobulinemia
2017

Acalabrutinib in mantle cell lymphoma

Kapoor, P. & Ansell, S. M., Jan 1 2017, (Accepted/In press) In : The Lancet.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
acalabrutinib
1 Citation (Scopus)

Advances in the understanding of IgM monoclonal gammopathy of undetermined significance

Paludo, J. & Ansell, S. M., Jan 1 2017, In : F1000Research. 6, 2142.

Research output: Contribution to journalReview article

Monoclonal Gammopathy of Undetermined Significance
Immunoglobulin M
Waldenstrom Macroglobulinemia
B-Cell Lymphoma
Non-Hodgkin's Lymphoma

Anti-CD20-IL-21 fusokine: The tail wags the dog

Ansell, S. M., Apr 20 2017, In : Blood. 129, 16, p. 2209-2210 2 p.

Research output: Contribution to journalComment/debate

Anti-Idiotypic Antibodies
Cytotoxicity
Antibodies
Tumors
Lymphoma

A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma

Dispenzieri, A., D'Souza, A., Gertz, M., Laumann, K., Wiseman, G., Lacy, M., LaPlant, B., Buadi, F., Hayman, S. R., Kumar, S. K., Dingli, D. M., Hogan, W., Ansell, S. M., Gastineau, D. A., Inwards, D. J., Micallef, I., Porrata, L. F., Johnston, P. B., Litzow, M. R. & Witzig, T. E., Oct 1 2017, In : Bone Marrow Transplantation. 52, 10, p. 1372-1377 6 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Multiple Myeloma
Stem Cells
Transplants
Melphalan
5 Citations (Scopus)

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

Rosenthal, A., Dueck, A., Ansell, S. M., Gano, K., Conley, C., Nowakowski, G. S., Camoriano, J. K., Leis, J. F., Mikhael, J. R., Stewart, A. K., Inwards, D., Dingli, D. M., Kumar, S. K., Noel, P., Gertz, M., Porrata, L., Russell, S. J., Colgan, J., Fonseca, R., Habermann, T. M. & 6 others, Kapoor, P., Buadi, F., Leung, N., Tiedemann, R., Witzig, T. E. & Reeder, C., May 1 2017, In : American Journal of Hematology. 92, 5, p. 467-472 6 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Cyclophosphamide
Dexamethasone
Lymphoma
B-Cell Lymphoma
4 Citations (Scopus)
Immunosuppression
Monocytes
Lymphoma
Cytokines
Lymphocytes
10 Citations (Scopus)

Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy

Farooq, U., Maurer, M. J., Thompson, C. A., Thanarajasingam, G., Inwards, D. J., Micallef, I., Macon, W., Syrbu, S., Lin, T., Lin, Y., Ansell, S. M., Nowakowski, G. S., Habermann, T. M., Cerhan, J. R. & Link, B. K., Oct 1 2017, In : British Journal of Haematology. 179, 1, p. 50-60 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Anthracyclines
Recurrence
Survival
Transplants
14 Citations (Scopus)
cohort analysis
disease incidence
Molecular Epidemiology
epidemiology
research program
6 Citations (Scopus)

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

Paludo, J., Abeykoon, J. P., Kumar, S. K., Shreders, A., Ailawadhi, S., Gertz, M., Kourelis, T., King, R., Reeder, C. B., Leung, N., Kyle, R. A., Buadi, F. K., Habermann, T. M., Dingli, D. M., Witzig, T. E., Dispenzieri, A., Lacy, M., Go, R. S., Lin, Y., Gonsalves, W. & 5 others, Warsame, R., Lust, J. A., Rajkumar, S. V., Ansell, S. M. & Kapoor, P., Oct 1 2017, In : British Journal of Haematology. 179, 1, p. 98-105 8 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cyclophosphamide
Dexamethasone
Confidence Intervals
Disease-Free Survival
43 Citations (Scopus)
Waldenstrom Macroglobulinemia
Guidelines
Stem Cell Transplantation
Therapeutics
Clinical Trials
4 Citations (Scopus)

Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma

Pianko, M. J., Funt, S. A., Page, D. B., Cattry, D., Scott, E. C., Ansell, S. M., Borrello, I. M., Gutierrez, M., Lendvai, N., Hassoun, H., Landgren, C. O. & Lesokhin, A. M., May 26 2017, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-4 4 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma

Bennani, N., LaPlant, B. R., Ansell, S. M., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Porrata, L. F., Colgan, J. P., Markovic, S. N., Nowakowski, G. S., Macon, W. R., Reeder, C. B., Mikhael, J. R., Northfelt, D. W., Ghobrial, I. M. & Witzig, T. E., May 1 2017, In : American Journal of Hematology. 92, 5, p. 448-453 6 p.

Research output: Contribution to journalArticle

Lymphoma
Therapeutics
Safety
Febrile Neutropenia
Everolimus
2 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Lymphoma
Central Nervous System
Clinical Trials
13 Citations (Scopus)

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery

Bryce, A. H., Egan, J. B., Borad, M. J., Stewart, A. K., Nowakowski, G. S., Chanan Khan, A. A., Patnaik, M. M., Ansell, S. M., Banck, M. S., Robinson, S., Mansfield, A., Klee, E. W., Oliver, G. R., McCormick, J. B., Huneke, N. E., Tagtow, C. M., Jenkins, R. B., Rumilla, K. M., Kerr, S. E., Kocher, J-P. & 5 others, Beck, S. A., Fernandez-Zapico, M. E., Farrugia, G., Lazaridis, K. N. & Mc Williams, R. R., 2017, In : Oncotarget. 8, 16, p. 27145-27154 10 p.

Research output: Contribution to journalArticle

Genomics
Neoplasms
Precision Medicine
Standard of Care
Therapeutics
16 Citations (Scopus)

Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma

Yang, Z. Z., Kim, H. J., Villasboas Bisneto, J. J. C. ., Chen, Y. P., Price-Troska, T. P., Jalali, S., Wilson, M., Novak, A. J. & Ansell, S. M., Sep 1 2017, In : Oncotarget. 8, 37, p. 61425-61439 15 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
T-Lymphocytes
Cytokines
Population
T-Cell Lymphoma
14 Citations (Scopus)

Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping

Wang, X., Luchtel, R., Dasari, S., Sidhu, J. S., Kadin, M. E., Macon, W. R., Ansell, S. M., Ketterling, R. P., Rech, K. L. & Feldman, A. L., Jun 1 2017, In : Human Pathology. 64, p. 19-27 9 p.

Research output: Contribution to journalArticle

Anaplastic Large-Cell Lymphoma
Proteins
Immunohistochemistry
Protein Isoforms
Fluorescence In Situ Hybridization
1 Citation (Scopus)

First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis

Chakraborty, R., Novak, A. J., Ansell, S. M., Muchtar, E., Kapoor, P., Hayman, S. R., Dispenzieri, A., Buadi, F. K., Lacy, M., King, R. & Gertz, M., Mar 16 2017, In : Amyloid. 24, p. 42-43 2 p.

Research output: Contribution to journalLetter

Amyloidosis
Immunoglobulin M
Light
Mutation
18 Citations (Scopus)

Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced-stage classical Hodgkin lymphoma

Connors, J. M., Ansell, S. M., Fanale, M., Park, S. I. & Younes, A., Sep 14 2017, In : Blood. 130, 11, p. 1375-1377 3 p.

Research output: Contribution to journalLetter

Antineoplastic Combined Chemotherapy Protocols
Immunoconjugates
Molecular Targeted Therapy
Remission Induction
Dacarbazine
4 Citations (Scopus)

Harnessing the power of the immune system in non-Hodgkin lymphoma: Immunomodulators, checkpoint inhibitors, and beyond

Ansell, S. M., Dec 8 2017, In : Hematology. 2017, 1, p. 618-621 4 p.

Research output: Contribution to journalArticle

Immunologic Factors
Non-Hodgkin's Lymphoma
Immune System
Lymphoma
B-Lymphocytes
7 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Everolimus
34 Citations (Scopus)

Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy

Gopal, A. K., Kahl, B. S., Flowers, C. R., Martin, P., Ansell, S. M., Abella-Dominicis, E., Koh, B., Ye, W., Barr, P. M., Salles, G. A. & Friedberg, J. W., Jun 1 2017, In : Blood. 129, 22, p. 3037-3039 3 p.

Research output: Contribution to journalReview article

1 Citation (Scopus)

Immunotherapy in lymphoma

Ansell, S. M., Caligaris-Cappio, F. & Maloney, D. G., Jun 1 2017, In : Hematological Oncology. 35, p. 88-91 4 p.

Research output: Contribution to journalArticle

Immunotherapy
Lymphoma
10 Citations (Scopus)

International assessment of event-free survival at 24 months and subsequent survival in peripheral T-cell lymphoma

Maurer, M. J., Ellin, F., Srour, L., Jerkeman, M., Bennani, N., Connors, J. M., Slack, G. W., Smedby, K. E., Ansell, S. M., Link, B. K., Cerhan, J. R., Relander, T., Savage, K. J. & Feldman, A. L., Dec 20 2017, In : Journal of Clinical Oncology. 35, 36, p. 4019-4026 8 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Disease-Free Survival
Survival
Recurrence
Retreatment
40 Citations (Scopus)

International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)

Younes, A., Hilden, P., Coiffier, B., Hagenbeek, A., Salles, G., Wilson, W., Seymour, J. F., Kelly, K., Gribben, J., Pfreunschuh, M., Morschhauser, F., Schoder, H., Zelenetz, A. D., Rademaker, J., Advani, R., Valente, N., Fortpied, C., Witzig, T. E., Sehn, L. H., Engert, A. & 30 others, Fisher, R. I., Zinzani, P. L., Federico, M., Hutchings, M., Bollard, C., Trneny, M., Elsayed, Y. A., Tobinai, K., Abramson, J. S., Fowler, N., Goy, A., Smith, M., Ansell, S. M., Kuruvilla, J., Dreyling, M., Thieblemont, C., Little, R. F., Aurer, I., Van Oers, M. H. J., Takeshita, K., Gopal, A., Rule, S., de Vos, S., Kloos, I., Kaminski, M. S., Meignan, M., Schwartz, L. H., Leonard, J. P., Schuster, S. J. & Seshan, V. E., Jul 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 7, p. 1436-1447 12 p.

Research output: Contribution to journalArticle

Lymphoma
Clinical Trials
Neoplasms
Fluorodeoxyglucose F18
Tumor Burden
6 Citations (Scopus)

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma

Bernatsky, S., García, H. A. V., Spinelli, J. J., Gaffney, P., Smedby, K. E., Ramsey-Goldman, R., Wang, S. S., Adami, H. O., Albanes, D., Angelucci, E., Ansell, S. M., WAsmann, Y., Becker, N., Benavente, Y., Berndt, S. I., Bertrand, K. A., Birmann, B. M., Boeing, H., Boffetta, P., Bracci, P. M. & 81 others, Brennan, P., Brooks-Wilson, A. R., Cerhan, J. R., Chanock, S. J., Clavel, J., Conde, L., Cotenbader, K. H., Cox, D. G., Cozen, W., Crouch, S., De Roos, A. J., De Sanjose, S., Di Lollo, S., Diver, W. R., Dogan, A., Foretova, L., Ghesquières, H., Giles, G. G., Glimelius, B., Habermann, T. M., Haioun, C., Hartge, P., Hjalgrim, H., Holford, T. R., Holly, E. A., Jackson, R. D., Kaaks, R., Kane, E., Kelly, R. S., Klein, R. J., Kraft, P., Kricker, A., Lan, Q., Lawrence, C., Liebow, M., Lightfoot, T., Link, B. K., Maynadie, M., McKay, J., Melbye, M., Molina, T. J., Monnereau, A., Morton, L. M., Nieters, A., North, K. E., Novak, A. J., Offit, K., Purdue, M. P., Rais, M., Riby, J., Roman, E., Rothman, N., Salles, G., Severi, G., Severson, R. K., Skibola, C. F., Slager, S. L., Smith, A., Smith, M. T., Southey, M. C., Staines, A., Teras, L. R., Thompson, C. A., Tilly, H., Tinker, L. F., Tjonneland, A., Turner, J., Vajdic, C. M., Vermeulen, R. C. H., Vijai, J., Vineis, P., Virtamo, J., Wang, Z., Weinstein, S., Witzig, T. E., Zelenetz, A., Zeleniuch-Jacquotte, A., Zhang, Y., Zheng, T., Zucca, M. & Clarke, A. E., Jan 1 2017, In : Lupus Science and Medicine. 4, 1, e000187.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Single Nucleotide Polymorphism
Alleles
Chromosomes
Lymphoma
24 Citations (Scopus)

Nivolumab in the treatment of Hodgkin lymphoma

Ansell, S. M., Apr 1 2017, In : Clinical Cancer Research. 23, 7, p. 1623-1626 4 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Reed-Sternberg Cells
Clinical Trials
Ligands
Therapeutics
93 Citations (Scopus)

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Ding, W. D., LaPlant, B. R., Call, T. G., Parikh, S. A., Leis, J. F., He, R., Shanafelt, T. D., Sinha, S., Le-Rademacher, J., Feldman, A. L., Habermann, T. M., Witzig, T. E., Wiseman, G. A., Lin, Y., Asmus, E., Nowakowski, G. S., Conte, M. J., Bowen, D. A., Aitken, C. N., Van Dyke, D. L. & 15 others, Greipp, P. T., Liu, X., Wu, X., Zhang, H., Secreto, C. R., Tian, S., Braggio, E. D., Wellik, L. E., Micallef, I., Viswanatha, D. S., Yan, H. D., Chanan Khan, A. A., Kay, N. E., Dong, H. M. & Ansell, S. M., Jun 29 2017, In : Blood. 129, 26, p. 3419-3427 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Tumors
Blocking Antibodies
Ligands
pembrolizumab

Peripheral T-cell lymphomas: very little good, mainly the bad and the ugly

Bennani, N. & Ansell, S. M., Jun 2 2017, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-2 2 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
10 Citations (Scopus)

Recommendations for clinical trial development in follicular lymphoma

Maddocks, K., Barr, P. M., Cheson, B. D., Little, R. F., Baizer, L., Kahl, B. S., Leonard, J. P., Fowler, N., Gordon, L. I., Link, B. K., Friedberg, J. W. & Ansell, S. M., 2017, In : Journal of the National Cancer Institute. 109, 3, djw255.

Research output: Contribution to journalReview article

Follicular Lymphoma
Clinical Trials
Therapeutics
Non-Hodgkin's Lymphoma
Biomarkers
6 Citations (Scopus)

Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma

Epperla, N., Pham, A. Q., Burnette, B. L., Wiseman, G. A., Habermann, T. M., Macon, W. R., Ansell, S. M., Inwards, D. J., Micallef, I., Johnston, P. B., Markovic, S. N., Porrata, L. F., Colgan, J. P., Ristow, K. M., Nowakowski, G. S. & Witzig, T. E., 2017, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Radioimmunotherapy
Follicular Lymphoma
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Therapeutics
38 Citations (Scopus)

Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, in patients with advanced solid tumors

Burris, H. A., Infante, J. R., Ansell, S. M., Nemunaitis, J. J., Weiss, G. R., Villalobos, V. M., Sikic, B. I., Taylor, M. H., Northfelt, D. W., Carson, W. E., Hawthorne, T. R., Davis, T. A., Yellin, M. J., Keler, T. & Bullock, T., Jun 20 2017, In : Journal of Clinical Oncology. 35, 18, p. 2028-2036 9 p.

Research output: Contribution to journalArticle

Anti-Idiotypic Antibodies
Safety
Neoplasms
T-Lymphocytes
Disease-Free Survival
76 Citations (Scopus)

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Merryman, R. W., Kim, H. T., Zinzani, P. L., Carlo-Stella, C., Ansell, S. M., Perales, M. A., Avigdor, A., Halwani, A. S., Houot, R., Marchand, T., Dhedin, N., Lescaut, W., Thiebaut-Bertrand, A., François, S., Stamatoullas-Bastard, A., Rohrlich, P. S., Wallet, H. L., Castagna, L., Santoro, A., Bachanova, V. & 11 others, Bresler, S. C., Srivastava, A., Kim, H., Pesek, E., Chammas, M., Reynolds, C., Ho, V. T., Antin, J. H., Ritz, J., Soiffer, R. J. & Armand, P., Mar 9 2017, In : Blood. 129, 10, p. 1380-1388 9 p.

Research output: Contribution to journalArticle

Transplants
Hematopoietic Stem Cells
Stem cells
Refractory materials
Lymphoma
20 Citations (Scopus)

Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients

Rossille, D., Azzaoui, I., Feldman, A. L., Maurer, M. J., Labouré, G., Parrens, M., Pangault, C., Habermann, T. M., Ansell, S. M., Link, B. K., Tarte, K., Witzig, T. E., Lamy, T., Slager, S. L., Roussel, M., Milpied, N., Cerhan, J. R. & Fest, T., Jan 27 2017, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle